Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Deal priced at a 2.8% discount to the prior closing level Shares of Haleon rose on Wednesday after the stake deal Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in ...

The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday. Shares in the maker of Sensodyne, Panadol and Advil, which gained 17% ...

Weybridge, England-based Haleon is a consumer healthcare products manufacturer that owns brands such as Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. Pfizer is a New ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

NEW YORK, Jan. 14 (Xinhua) -- Pfizer Inc., the American multinational pharmaceutical and biotechnology corporation, is offering around 700 million shares in Haleon Plc, representing a roughly 7.7 ...